Xwell Inc
NASDAQ:XWEL

Watchlist Manager
Xwell Inc Logo
Xwell Inc
NASDAQ:XWEL
Watchlist
Price: 1.19 USD -2.46% Market Closed
Market Cap: $9.4m

Xwell Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Xwell Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Xwell Inc
NASDAQ:XWEL
Free Cash Flow
-$11.7m
CAGR 3-Years
31%
CAGR 5-Years
17%
CAGR 10-Years
-16%
Carriage Services Inc
NYSE:CSV
Free Cash Flow
$40.1m
CAGR 3-Years
5%
CAGR 5-Years
-10%
CAGR 10-Years
11%
Service Corporation International
NYSE:SCI
Free Cash Flow
$554.2m
CAGR 3-Years
7%
CAGR 5-Years
-1%
CAGR 10-Years
6%
H & R Block Inc
NYSE:HRB
Free Cash Flow
$598.8m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADT Inc
NYSE:ADT
Free Cash Flow
$715.9m
CAGR 3-Years
26%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Frontdoor Inc
NASDAQ:FTDR
Free Cash Flow
$390m
CAGR 3-Years
57%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Xwell Inc
Glance View

XpresSpa Group, Inc. provides global travel health and wellness services. The company is headquartered in New York City, New York and currently employs 363 full-time employees. The company went IPO on 2010-06-18. The firm operates four brands: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products, with 26 locations in 13 airports globally. Treat is a travel health and wellness brand, the fully integrated in-airport spa and wellness concept, providing medical services, testing, and a holistic approach to physical and mental well-being at three domestic airport locations. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting biosurveillance monitoring in its airport locations to identify existing and new SARS-CoV-2 variants. HyperPointe is a digital healthcare and data analytics relationship company serving the global healthcare industry.

XWEL Intrinsic Value
1.96 USD
Undervaluation 39%
Intrinsic Value
Price $1.19

See Also

What is Xwell Inc's Free Cash Flow?
Free Cash Flow
-11.7m USD

Based on the financial report for Dec 31, 2025, Xwell Inc's Free Cash Flow amounts to -11.7m USD.

What is Xwell Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-16%

Over the last year, the Free Cash Flow growth was 9%. The average annual Free Cash Flow growth rates for Xwell Inc have been 31% over the past three years , 17% over the past five years , and -16% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett